Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Scotiabank Downgrades Braskem to Sector Underperform

Scotiabank Downgrades Braskem to Sector Underperform

Scotiabank analyst Ben Isaacson downgrades Braskem (NYSE:BAK) from Sector Perform to Sector Underperform.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Scotiabank analyst Ben Isaacson downgrades Braskem (NYSE:BAK) from Sector Perform to Sector Underperform.

Analyst Ratings

Analyst Ratings for Cullinan Oncology

By Benzinga Insights

August 9, 2:00 PM

Within the last quarter, Cullinan Oncology (NASDAQ:CGEM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

CGEM

Legett & Platt Lowers FY23 Guidance EPS $1.45-$1.65 Vs $1.63 Est.; Revenue $4.75B-$4.95B Vs $4.94B Est.

By Happy Mohamed

July 31, 4:18 PM

2023 GUIDANCE Full year 2023 sales and EPS guidance lowered Sales are expected to be $4.75–$4.95 billion, -4% to -8% versus 2022 Volume at the midpoint expected

LEG

RBC Capital Maintains Outperform on AECOM, Raises Price Target to $91

By Benzinga Newsdesk

November 15, 8:57 AM

RBC Capital analyst Arthur Nagorny maintains AECOM (NYSE:ACM) with a Outperform and raises the price target from $87 to $91.

ACM

Transition Of Commercial Fleets To EVs: Ford Launches New Charger Lineup For Clients

By Nabaparna Bhattacharya

August 29, 10:44 AM

Ford Pro, the commercial division within Ford Motor Company (NYSE: F), launched charging solutions for

Scotiabank Downgrades Braskem to Sector Underperform

Related Posts

Analyst Ratings for Cullinan Oncology

Legett & Platt Lowers FY23 Guidance EPS $1.45-$1.65 Vs $1.63 Est.; Revenue $4.75B-$4.95B Vs $4.94B Est.

RBC Capital Maintains Outperform on AECOM, Raises Price Target to $91

Transition Of Commercial Fleets To EVs: Ford Launches New Charger Lineup For Clients